Controversies in Primary Care

OSUWexnerbloglogo2014 Controversies in Primary Care is the topic of our latest webcast. What Galileo taught was that sometimes the most widely accepted dogma isn’t always right. Controversies still exist in medicine and today, we’re going to take an in depth look at one of the more pressing controversies in primary care medicine, whether and how patients with pre-diabetes should be treated. In the studio, with our Moderator Dr. Jim Allen, is Assistant Professor of Internal Medicine from the Division of General Internal Medicine at The Ohio State University Wexner Medical Center, Dr. Kevin Goist.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of recognizing pre-diabetes; and DISCUSS the potential treatments for pre-diabetes

You’ll also learn about the following:

  • The evolving concept of pre-diabetes
  • Risk factors for developing diabetes
  • Preventing diabetes and pre-diabetes
  • Timing of screening for pre-diabetes
  • Whether children should be screened
  • When to discontinue treatment for pre-diabetes
  • Cost of treatment
  • Pre-hypertension and pre-hyperlipidemia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

View Update on Sleep Apnea

OSUWexnerbloglogo2014 View Update on Sleep Apnea. It wasn’t until 1965 that the first polysomnograph recorded apneas during sleep and it wasn’t until 1970 that the first sleep clinic was established at Stanford University in California. On this CME webcast, we’re going to show you how far we’ve come since that first sleep study was done 50 years ago. Joining our moderator, Dr. Jim Allen, in the studio is sleep medicine specialist and pulmonologist Dr. Aneesa Das and otolaryngologist Dr. Eugene Chio.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients at risk for obstructive sleep apnea; DESCRIBE primary non-surgical treatments for obstructive sleep apnea; UNDERSTAND surgical options for OSA; and UNDERSTAND patient selection for sleep surgery.

You’ll also learn about the following:

  • The relation between obesity and sleep apnea
  • Surgical options for sleep apnea
  • CPAP versus BiPAP in sleep apnea
  • New CPAP technologies
  • The most common sleep apnea surgeries
  • Whether patients can stop CPAP after surgery
  • Weight loss and sleep apnea control
  • Tracheostomy for sleep apnea
  • Central sleep apnea
  • Anesthesia for sleep apnea surgery and post-op recovery
  • Post-surgical sleep assessment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn On-line about Healthcare Financing 101

OSUWexnerbloglogo2014Learn On-line about Healthcare Financing 101.  On this CME Webcast, we’re going to take a close-up look at how American healthcare financing works.  How Medicare sets its fees and how you are an integral part of the process that determines the Medicare fee schedule.  To do it, we’re going to take you to business school for Healthcare Financing 101. We’re absolutely delighted to welcome today’s guests to the studio with Dr. Jim Allen. First, we have Associate Professor and the Vice Chairman for Clinical Affairs for the OSU Department of Internal Medicine, Dr. Stephen Hoffmann.  Also joining us is the Chief Financial Officer for OSU Physicians, incorporated, the physician practice group at Ohio State, Richard Sobieray.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the RUC, Relative Value Unit (RVUs), and Current Procedural Terminology (CPT); RECOGNIZE the components of a total RVU ; and DESCRIBE Patient Service Revenue and Gross Patient Service Revenue (GPSR).

You’ll also learn about the following:

  • The RVU system
  • Effect of Medicare reimbursement policy on commercial insurance
  • The RVU system and physician specialty choice
  • SGR: the Medicare sustainable growth rate controversy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understand Resistant Hypertension with On-line Education

OSUWexnerbloglogo2014Understand Resistant Hypertension with On-line Education. On this MedNet21 CME Webcast, we’re going to hear more about resistant hypertension: what some of the causes are, what the pharmacologic approach is, and how a new endovascular procedure might hold the promise of improved blood pressure control for these patients in the future.  Let me welcome today’s guests in the studio with Dr. Jim Allen.  First, we have from the Division of Nephrology, Assistant Professor of Internal Medicine Dr. Christopher Valentine. Joining him from the Division of Cardiovascular Medicine is Associate Professor of Internal Medicine and the Medical Director of the Richard M. Ross Heart Hospital at the Wexner Medical Center, Dr. Ernest Mazzaferri.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW secondary causes of hypertension; Discuss therapy of resistant hypertension; and RECOGNIZE the Role of Sympathetic N.S. in HTN.

You’ll also learn about the following:

  • Epidemiology of resistant hypertension
  • Consequences of inadequately treated hypertension
  • The future of catheter-based renal denervation
  • Patient selection for renal denervation
  • An On-line Webcast about Secondary Causes of Hypertension
  • Lab testing of patients with resistant hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.